The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
MicroRNA‐10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC
Open accessAbstract
MicroRNAs (miRNAs) are effective post‐transcriptional regulators of gene expression and are important in many biological processes. Although the oncogenic and tumor suppressive functions of several miRNAs have been characterized, the role of miRNAs in mediating tumor invasion and migration remains largely unexplored. Recently, miR‐10b was identified as an miRNA highly expressed in metastatic breast cancer, promoting cell migration and invasion. Here, we performed real‐time reverse transcriptase polymerase chain reaction (RT‐PCR) assays on 43 glioma samples (17 glioblastoma, 6 anaplastic astrocytoma, 10 low‐grade astrocytoma, 6 oligodendroglioma and 4 ependymoma) and 6 glioma cell lines. We found that miR‐10b expression was upregulated in all glioma samples compared to non‐neoplastic brain tissues. The expression levels of miR‐10b were associated with higher grade glioma. In addition, mRNA expressions of RhoC and urokinase‐type plasminogen activator receptor (uPAR), which were thought to be regulated by miR‐10b via HOXD10, were statistically significantly correlated with the expression of miR‐10b (p < 0.001, p = 0.001, respectively). Also, protein expression levels of RhoC and uPAR were associated with expression levels of miR‐10b (p = 0.009, p = 0.014, respectively). Finally, multifocal lesions on enhanced MRI of 7 malignant gliomas were associated with higher expression levels of miR‐10b (p = 0.02). Our data indicated that miR‐10b might play some role in the invasion of glioma cells. © 2009 UICC
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
Ma, L., Teruya-Feldstein, J., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06174 · Cited by 2,605
MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells
Chan, J. A., Krichevsky, A. M., & Kosik, K. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0137 · Cited by 2,557
Endogenous human microRNAs that suppress breast cancer metastasis
Tavazoie, S. F., Alarcón, C., Oskarsson, T., Padua, D., Wang, Q., Bos, P. D., Gerald, W. L., & Massagué, J. (2008) · Nature · doi:10.1038/nature06487 · Cited by 1,857
Burridge, K., & Wennerberg, K. (2004) · Cell · doi:10.1016/s0092-8674(04)00003-0 · Cited by 1,578
Impaired microRNA processing enhances cellular transformation and tumorigenesis
Kumar, M. S., Lu, J., Mercer, K. L., Golub, T. R., & Jacks, T. (2007) · Nature Genetics · doi:10.1038/ng2003 · Cited by 1,463
Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs
Bartel, D. P., & Chen, C.-Z. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1328 · Cited by 1,425
Ribo-gnome: The Big World of Small RNAs
Zamore, P. D., & Haley, B. (2005) · Science · doi:10.1126/science.1111444 · Cited by 1,288
A Genetic Screen Implicates miRNA-372 and miRNA-373 As Oncogenes in Testicular Germ Cell Tumors
Voorhoeve, P. M., le Sage, C., Schrier, M., Gillis, A. J. M., Stoop, H., Nagel, R., Liu, Y.-P., van Duijse, J., Drost, J., Griekspoor, A., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.037 · Cited by 1,264
Extensive modulation of a set of microRNAs in primary glioblastoma
Ciafrè, S. A., Galardi, S., Mangiola, A., Ferracin, M., Liu, C.-G., Sabatino, G., Negrini, M., Maira, G., Croce, C. M., & Farace, M. G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.030 · Cited by 1,096
MicroRNA-21 targets tumor suppressor genes in invasion and metastasis
Zhu, S., Wu, H., Wu, F., Nie, D., Sheng, S., & Mo, Y.-Y. (2008) · Cell Research · doi:10.1038/cr.2008.24 · Cited by 1,051
The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis
Huang, Q., Gumireddy, K., Schrier, M., le Sage, C., Nagel, R., Nair, S., Egan, D. A., Li, A., Huang, G., Klein-Szanto, A. J., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1681 · Cited by 975
MicroRNA-21 targets tumor suppressor genes in invasion and metastasis
Shuomin, Zhu, Hailong, H., Wu, Fangting, Daotai, Nie, Shijie, Sheng, Yin-Yuan, et al. (2008) · Cell Research · Cited by 831
Regulation of the p27Kip1 tumor suppressor by miR‐221 and miR‐222 promotes cancer cell proliferation
le Sage, C., Nagel, R., Egan, D. A., Schrier, M., Mesman, E., Mangiola, A., Anile, C., Maira, G., Mercatelli, N., Ciafrè, S. A., et al. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601790 · Cited by 815
Ladeiro, Y., Couchy, G., Balabaud, C., Bioulac-Sage, P., Pelletier, L., Rebouissou, S., & Zucman-Rossi, J. (2008) · Hepatology · doi:10.1002/hep.22256 · Cited by 684
深井順也, & 西尾, 和. (2006) · Mebio oncology · Cited by 558
Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin
Garzon, R., Garofalo, M., Martelli, M. P., Briesewitz, R., Wang, L., Fernandez-Cymering, C., Volinia, S., Liu, C.-G., Schnittger, S., Haferlach, T., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800135105 · Cited by 500
Molecular targets of glioma invasion
Nakada, M., Nakada, S., Demuth, T., Tran, N. L., Hoelzinger, D. B., & Berens, M. E. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6342-5 · Cited by 387
Identification of microRNAs and Other Tiny Noncoding RNAs by cDNA Cloning
Ambros, V., & Lee, R. C. (2004) · RNA Interference, Editing, and Modification · doi:10.1385/1-59259-775-0:131 · Cited by 184
TWIST is Expressed in Human Gliomas, Promotes Invasion
Elias, M. C., Tozer, K. R., Silber, J. R., Mikheeva, S., Deng, M., Morrison, R. S., Manning, T. C., Silbergeld, D. L., Glackin, C. A., Reh, T. A., et al. (2005) · Neoplasia · doi:10.1593/neo.04352 · Cited by 176
Proteases in brain tumour progression
Levičar, N., Nutall, R. K., & Lah, T. T. (2003) · Acta Neurochirurgica · doi:10.1007/s00701-003-0097-z · Cited by 159
Mohanam, S., Sawaya, R. A., McCutcheon, I. E., Ali‐Osman, F., Boyd, D. D., & Rao, J. (1993) · PubMed · Cited by 156
Integrins: Molecular determinants of glioma invasion
D’Abaco, G. M., & Kaye, A. H. (2007) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2007.06.019 · Cited by 153
Expression and localization of urokinase-type plasminogen activator receptor in human gliomas.
Yamamoto, M., Sawaya, R. A., Mohanam, S., Rao, V. H., Bruner, J. M., Nicolson, G. L., & Rao, J. S. (1994) · PubMed · Cited by 149
Sustained Expression of Homeobox D10 Inhibits Angiogenesis
Myers, C. A., Charboneau, A. L., Cheung, I., Hanks, D. K., & Boudreau, N. J. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64488-4 · Cited by 149
Zhai, G. G., Malhotra, R. K., Delaney, M. A., Latham, D. E., Nestler, U., Zhang, M., Mukherjee, N., Song, Q., Robe, P. A. J. T., & Chakravarti, A. (2005) · Journal of Neuro-Oncology · doi:10.1007/s11060-005-6499-4 · Cited by 112
Diffuse brain invasion of glioma cells requires beta 1 integrins.
Paulus, W., Baur, I., Beutler, A. S., & Reeves, S. A. (1996) · PubMed · Cited by 103
MicroRNA Involvement in Brain Tumors: From Bench to Bedside
Nicoloso, M. S., & Calin, G. A. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00119.x · Cited by 101
MicroRNA expression profiling: A molecular tool for defining the phenotype of hepatocellular tumors
Braconi, C., & Patel, T. C. (2008) · Hepatology · doi:10.1002/hep.22326 · Cited by 71
Faried, A., Faried, L. S., Usman, N., Kato, H., & Kuwano, H. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9562-x · Cited by 55
RhoC is essential for the metastasis of gastric cancer
Liu, N., Zhang, G., Bi, F., Pan, Y., Xue, Y., Shi, Y., Yao, L., Zhao, L., Zheng, Y., & Fan, D. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0217-y · Cited by 52
MicroRNA and Brain Tumors: A Cause and a Cure?
Mathupala, S. P., Mittal, S., Guthikonda, M., & Sloan, A. E. (2007) · DNA and Cell Biology · doi:10.1089/dna.2006.0560 · Cited by 31
Cited by
Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model
Ma, L., Reinhardt, F., Pan, E., Soutschek, J., Bhat, B., Marcusson, E. G., Teruya-Feldstein, J., Bell, G. W., & Weinberg, R. A. (2010) · Nature Biotechnology · doi:10.1038/nbt.1618 · Cited by 772
miRNA: A Promising Therapeutic Target in Cancer
Menon, A., Abd-Aziz, N., Khalid, K., Poh, C. L., & Naidu, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911502 · Cited by 357
Teplyuk, N. M., Mollenhauer, B., Gabriely, G., Giese, A., Kim, E., Smolsky, M., Kim, R. Y., Saria, M. G., Pastorino, S., Kesari, S., et al. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos074 · Cited by 302
MicroRNA control of epithelial–mesenchymal transition and metastasis
Zhang, J., & Ma, L. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9368-6 · Cited by 273
Human Glioma Growth Is Controlled by MicroRNA-10b
Gabriely, G., Yi, M., Narayan, R. S., Niers, J. M., Wurdinger, T., Imitola, J., Ligon, K. L., Kesari, S., Esau, C., Stephens, R. M., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3568 · Cited by 266
Metadata
- Authors
- Sasayama, T., Nishihara, M., Kondoh, T., Hosoda, K., & Kohmura, E.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2009-07-14
- Volume
- 125
- Issue
- 6
- Pages
- 1407-1413
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1972380031
- Cited by
- 297
- References
- 33
- FWCI
- 8.55
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.